Skip to main content
. 2017 Sep 28;8(65):109723–109731. doi: 10.18632/oncotarget.21299

Figure 2. Efficacy of sorafenib for recurrence rate Shows forest plot of risk ratio of recurrence rate of patients with hepatocellular carcinoma after resection who treated with sorafenib versus control.

Figure 2

Data of 4 studies were pooled using fixed-effects model. Studies are sorted by publication year.